IDEX Corporation

As of June 30, 2026, IDEX Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh carries a market capitalization of 90.75B, placing it among publicly traded companies globally. Its enterprise value stands at 97.28B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

IDEX Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh's next confirmed earnings release is scheduled for October 28, 2026.

As of June 30, 2026, IDEX Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh has 1.58B shares outstanding.

As of June 30, 2026, IDEX Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh trades at a trailing price-to-earnings ratio of 33.91. The price-to-sales ratio is 4.91, and the price-to-book ratio stands at 4.38.

As of June 30, 2026, IDEX Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh trades at an EV/EBITDA multiple of 19.72 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 5.25 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 25.37 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. IDEX Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh trades at an EV/FCF ratio of 24.59, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 97.28B versus a market cap of 90.75B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, IDEX Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh maintains a current ratio of 3.05, meaning it holds 3.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 47.06, indicating elevated leverage, while an interest coverage ratio of 14.96 demonstrates strong ability to service its debt obligations.

Over the twelve months ended June 30, 2026, IDEX Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh posted a return on equity (ROE) of 12.96, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 9.58 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 7.53, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 9.65, useful for judging operating efficiency across full business cycles. The company generates approximately 2.11M in revenue per employee across its workforce of 8,775.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 3.93 indicates how many times IDEX Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, IDEX Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh recorded 837.38M in income tax expense. That works out to an effective tax rate of 23.78, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 3.52B, leaving 2.69B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on July 27, 2026, IDEX Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh's stock has gained approximately 10.07% over the past 52 weeks. The 50-day moving average sits at 53.44, while the 200-day moving average is 49.42.

Over the twelve months ended June 30, 2026, IDEX Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh generated 18.53B in revenue and converted that into 2.69B in net income, yielding earnings per share of 1.69. EBITDA reached 4.93B, while operating income came in at 3.90B.

As of June 30, 2026, IDEX Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh holds 3.21B in cash and equivalents against 9.75B in total debt, resulting in a net debt position of 6.40B. Total book value stands at 20.72B, with working capital of 6.16B providing operational flexibility.

IDEX Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh produced 3.70B in operating cash flow over the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, IDEX Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh posted a gross margin of 44.70, reflecting its pricing power and cost economics. The operating margin of 21.04 and net profit margin of 14.49 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, IDEX Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh paid dividends of 0.69 per share. The dividend payout ratio of 41.11 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 4.06, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 2.80, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to IDEX Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh shareholders.

As of June 30, 2026, IDEX Corporation Shs Unsponsored Brazilian Depositary Receipt Repr 0.05 Sh has an Altman Z-Score of 9.49, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.